211 related articles for article (PubMed ID: 35063130)
1. Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes.
Inoue H; Nakamura S; Higo S; Shiba M; Kohama Y; Kondo T; Kameda S; Tabata T; Okuno S; Ikeda Y; Li J; Liu L; Yamazaki S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Stem Cell Reports; 2022 Feb; 17(2):337-351. PubMed ID: 35063130
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
[TBL] [Abstract][Full Text] [Related]
4. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
5. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
[TBL] [Abstract][Full Text] [Related]
6. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
7. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
8. Sodium current abnormalities and deregulation of Wnt/β-catenin signaling in iPSC-derived cardiomyocytes generated from patient with arrhythmogenic cardiomyopathy harboring compound genetic variants in plakophilin 2 gene.
Khudiakov A; Zaytseva A; Perepelina K; Smolina N; Pervunina T; Vasichkina E; Karpushev A; Tomilin A; Malashicheva A; Kostareva A
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165915. PubMed ID: 32768677
[TBL] [Abstract][Full Text] [Related]
9. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
Cerrone M; Lin X; Zhang M; Agullo-Pascual E; Pfenniger A; Chkourko Gusky H; Novelli V; Kim C; Tirasawadichai T; Judge DP; Rothenberg E; Chen HS; Napolitano C; Priori SG; Delmar M
Circulation; 2014 Mar; 129(10):1092-103. PubMed ID: 24352520
[TBL] [Abstract][Full Text] [Related]
10. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
[TBL] [Abstract][Full Text] [Related]
11. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Characterization of a Human In Vitro Model of Arrhythmogenic Cardiomyopathy Under Topological and Mechanical Stimuli.
Martewicz S; Luni C; Serena E; Pavan P; Chen HV; Rampazzo A; Elvassore N
Ann Biomed Eng; 2019 Mar; 47(3):852-865. PubMed ID: 30569242
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmogenic cardiomyopathy: An in-depth look at molecular mechanisms and clinical correlates.
Costa S; Cerrone M; Saguner AM; Brunckhorst C; Delmar M; Duru F
Trends Cardiovasc Med; 2021 Oct; 31(7):395-402. PubMed ID: 32738304
[TBL] [Abstract][Full Text] [Related]
14. Generation of CRISPR/Cas9 edited human induced pluripotent stem cell line carrying the heterozygous p.H695VfsX5 frameshift mutation in the exon 10 of the PKP2 gene.
Pierre B; Laëtitia DB; Camille B; Claire P; Elise B; Estelle G; Vincent F; Eric V
Stem Cell Res; 2024 Apr; 76():103341. PubMed ID: 38382214
[TBL] [Abstract][Full Text] [Related]
15. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal cell junction assembly in human iPSC-CM models of arrhythmogenic cardiomyopathy.
Kim SL; Trembley MA; Lee KY; Choi S; MacQueen LA; Zimmerman JF; de Wit LHC; Shani K; Henze DE; Drennan DJ; Saifee SA; Loh LJ; Liu X; Parker KK; Pu WT
Stem Cell Reports; 2023 Sep; 18(9):1811-1826. PubMed ID: 37595583
[TBL] [Abstract][Full Text] [Related]
17. Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes.
Sato PY; Musa H; Coombs W; Guerrero-Serna G; Patiño GA; Taffet SM; Isom LL; Delmar M
Circ Res; 2009 Sep; 105(6):523-6. PubMed ID: 19661460
[TBL] [Abstract][Full Text] [Related]
18. Plakophilin 2 couples actomyosin remodeling to desmosomal plaque assembly via RhoA.
Godsel LM; Dubash AD; Bass-Zubek AE; Amargo EV; Klessner JL; Hobbs RP; Chen X; Green KJ
Mol Biol Cell; 2010 Aug; 21(16):2844-59. PubMed ID: 20554761
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenic right ventricular cardiomyopathy plakophilin-2 mutations disrupt desmosome assembly and stability.
Hall C; Li S; Li H; Creason V; Wahl JK
Cell Commun Adhes; 2009; 16(1-3):15-27. PubMed ID: 19533476
[TBL] [Abstract][Full Text] [Related]
20. Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes.
Blazeski A; Lowenthal J; Wang Y; Teuben R; Zhu R; Gerecht S; Tomaselli G; Tung L
Tissue Eng Part A; 2019 May; 25(9-10):725-735. PubMed ID: 30520705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]